Samuli Eldfors, PhD

Citée par

	Toutes	Depuis 2019
Citations	3804	2325
indice h	25	25
indice i10	32	30

520

260

130

390

201220132014201520162017201820192020202120222023202437 130 186 230 236 276 353 385 407 507 428 440 157

Accès public

Tout afficher

30 articles

3 articles

disponibles

non disponibles

Sur la base des exigences liées au financement

Coauteurs

Caroline HeckmanUniversity of Helsinki, Institute for Molecular Medicine Finland FIMM-HiLIFEAdresse e-mail validée de helsinki.fi
Kimmo PorkkaProfessor of hematology, Helsinki University Hospital Cancer CenterAdresse e-mail validée de helsinki.fi
Olli KallioniemiDirector, Science for Life Laboratory and the data-driven life science programAdresse e-mail validée de scilifelab.se
Satu MustjokiUniversity of HelsinkiAdresse e-mail validée de helsinki.fi
Sonja LagströmScientistAdresse e-mail validée de agilent.com
Mika KontroHelsinki University Hospital and Institute for Molecular Medicine FinlandAdresse e-mail validée de helsinki.fi
Krister WennerbergBRIC, University of CopenhagenAdresse e-mail validée de fimm.fi
MM MajumderInstitute for Molecular Medicine Finland(FIMM), University of HelsinkiAdresse e-mail validée de fimm.fi
Heikki KuusanmäkiInstitute for Molecular Medicine Finland (FIMM), University of HelsinkiAdresse e-mail validée de helsinki.fi
Dr. Bhagwan Yadav, PhDUniversity of HelsinkiAdresse e-mail validée de helsinki.fi
jarek maciejewskiAdresse e-mail validée de ccf.org
Tea Pemovska, PhDSenior Postdoctoral Researcher at Medical University of ViennaAdresse e-mail validée de meduniwien.ac.at
Thomas OlsonVirginia Commonwealth University HealthAdresse e-mail validée de vcuhealth.org
Bjorn T. GjertsenProfessor of Hematology, University of BergenAdresse e-mail validée de uib.no
Ashwini KumarSenior Scientist Johnson & Johnson R&DAdresse e-mail validée de helsinki.fi
Tero AittokallioUniversity of Helsinki, University of Turku, University of OsloAdresse e-mail validée de utu.fi
Disha MalaniInstitute for Molecular Medicine Finland (FIMM), University of HelsinkiAdresse e-mail validée de helsinki.fi
Tiina KelkkaAdresse e-mail validée de helsinki.fi
Sabrina BortoluzziTechnical University MunichAdresse e-mail validée de tum.de
Riikka KarjalainenAdresse e-mail validée de helsinki.fi

Suivre

Samuli Eldfors, PhD

Research Fellow, MGH, Harvard Medical School

Adresse e-mail validée de mgh.harvard.edu

Leukemia Cancer Precision Medicine Hematology Bioinformatics


Titre Trier par citations Trier par année Trier par titre	Citée par Citée par	Année
Somatic STAT3 Mutations in Large Granular Lymphocytic Leukemia HLM Koskela, S Eldfors, P Ellonen, AJ van Adrichem, H Kuusanmäki, ... New England Journal of Medicine 366 (20), 1905-1913, 2012	849	2012
Individualized Systems Medicine Strategy to Tailor Treatments for Patients with Chemorefractory Acute Myeloid LeukemiaISM Approach to Therapy Selection T Pemovska, M Kontro, B Yadav, H Edgren, S Eldfors, A Szwajda, ... Cancer discovery 3 (12), 1416-1429, 2013	449*	2013
Comparison of solution-based exome capture methods for next generation sequencing AM Sulonen, P Ellonen, H Almusa, M Lepistö, S Eldfors, S Hannula, ... Genome biology 12, 1-18, 2011	328	2011
Discovery of somatic STAT5b mutations in large granular lymphocytic leukemia HLM Rajala, S Eldfors, H Kuusanmäki, AJ Van Adrichem, T Olson, ... Blood, The Journal of the American Society of Hematology 121 (22), 4541-4550, 2013	321	2013
Autoimmunity, hypogammaglobulinemia, lymphoproliferation, and mycobacterial disease in patients with activating mutations in STAT3 EM Haapaniemi, M Kaustio, HLM Rajala, AJ van Adrichem, L Kainulainen, ... Blood, The Journal of the American Society of Hematology 125 (4), 639-648, 2015	292	2015
Aggressive natural killer-cell leukemia mutational landscape and drug profiling highlight JAK-STAT signaling as therapeutic target O Dufva, M Kankainen, T Kelkka, N Sekiguchi, SA Awad, S Eldfors, ... Nature communications 9 (1), 1567, 2018	128	2018
Novel activating STAT5B mutations as putative drivers of T-cell acute lymphoblastic leukemia M Kontro, H Kuusanmäki, S Eldfors, T Burmeister, EI Andersson, ... Leukemia 28 (8), 1738-1742, 2014	126	2014
Somatic mutations in clonally expanded cytotoxic T lymphocytes in patients with newly diagnosed rheumatoid arthritis P Savola, T Kelkka, HL Rajala, A Kuuliala, K Kuuliala, S Eldfors, ... Nature communications 8 (1), 15869, 2017	106	2017
High incidence of activating STAT5B mutations in CD4-positive T-cell large granular lymphocyte leukemia EI Andersson, T Tanahashi, N Sekiguchi, VR Gasparini, S Bortoluzzi, ... Blood, The Journal of the American Society of Hematology 128 (20), 2465-2468, 2016	106	2016
Comprehensive drug testing of patient-derived conditionally reprogrammed cells from castration-resistant prostate cancer K Saeed, V Rahkama, S Eldfors, D Bychkov, JP Mpindi, B Yadav, ... European urology 71 (3), 319-327, 2017	95	2017
Activating somatic mutations outside the SH2-domain of STAT3 in LGL leukemia E Andersson, H Kuusanmäki, S Bortoluzzi, S Lagström, A Parsons, ... Leukemia 30 (5), 1204-1208, 2016	90	2016
HOX gene expression predicts response to BCL-2 inhibition in acute myeloid leukemia M Kontro, A Kumar, MM Majumder, S Eldfors, A Parsons, T Pemovska, ... Leukemia 31 (2), 301-309, 2017	89	2017
Discovery of novel drug sensitivities in T-PLL by high-throughput ex vivo drug testing and mutation profiling EI Andersson, S Pützer, B Yadav, O Dufva, S Khan, L He, L Sellner, ... Leukemia 32 (3), 774-787, 2018	86	2018
Implementing a functional precision medicine tumor board for acute myeloid leukemia D Malani, A Kumar, O Brück, M Kontro, B Yadav, M Hellesøy, ... Cancer Discovery 12 (2), 388-401, 2022	85	2022
Novel somatic mutations in large granular lymphocytic leukemia affecting the STAT-pathway and T-cell activation EI Andersson, HLM Rajala, S Eldfors, P Ellonen, T Olson, A Jerez, ... Blood cancer journal 3 (12), e168-e168, 2013	76	2013
Dasatinib and navitoclax act synergistically to target NUP98-NSD1⁺/FLT3-ITD⁺ acute myeloid leukemia JL Kivioja, A Thanasopoulou, A Kumar, M Kontro, B Yadav, MM Majumder, ... Leukemia 33 (6), 1360-1372, 2019	55	2019
Enhanced sensitivity to glucocorticoids in cytarabine-resistant AML D Malani, A Murumägi, B Yadav, M Kontro, S Eldfors, A Kumar, ... Leukemia 31 (5), 1187-1195, 2017	54	2017
Idelalisib sensitivity and mechanisms of disease progression in relapsed TCF3-PBX1 acute lymphoblastic leukemia S Eldfors, H Kuusanmäki, M Kontro, MM Majumder, A Parsons, H Edgren, ... Leukemia 31 (1), 51-57, 2017	52	2017
Mutation accumulation in cancer genes relates to nonoptimal outcome in chronic myeloid leukemia S Adnan Awad, M Kankainen, T Ojala, P Koskenvesa, S Eldfors, ... Blood advances 4 (3), 546-559, 2020	51	2020
Converging endometrial and ovarian tumorigenesis in Lynch syndrome: Shared origin of synchronous carcinomas A Niskakoski, A Pasanen, N Porkka, S Eldfors, H Lassus, ... Gynecologic oncology 150 (1), 92-98, 2018	46	2018

Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.

Articles 1–20

Nombre de citations par an

Citations en double

Citations fusionnées

Ajouter les coauteursCoauteurs

Suivre

Citée par

Coauteurs